Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q1 2025 · 10-Q
Revenue$8.49M$8.49M+11.1% vs Q1 2024 Net Income-$6.03M-$6.03MN/M vs Q1 2024 EPS Diluted-$0.22-$0.22N/M vs Q1 2024 Gross Profit$5,132,000+13.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
Operating Cash Flow-$6,172,000N/M Free Cash Flowderived-$6,355,000N/M Margins · derivedGross margin60.5%+1.2 pt vs Q1 2024
Operating margin-72.6%−17.4 pt vs Q1 2024
Net margin-71.0%−16.7 pt vs Q1 2024
ended Mar 31, 2025 · filed May 13, 2025 · 43 d after period end